Annual Retained Earnings
$482.56 M
+$1.32 M+0.27%
31 December 2023
Summary:
Supernus Pharmaceuticals annual retained earnings is currently $482.56 million, with the most recent change of +$1.32 million (+0.27%) on 31 December 2023. During the last 3 years, it has risen by +$102.64 million (+27.02%). SUPN annual retained earnings is now at all-time high.SUPN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$541.10 M
+$38.50 M+7.66%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly retained earnings is currently $541.10 million, with the most recent change of +$38.50 million (+7.66%) on 30 September 2024. Over the past year, it has increased by +$58.54 million (+12.13%). SUPN quarterly retained earnings is now at all-time high.SUPN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +12.1% |
| 3 y3 years | +27.0% | +42.4% |
| 5 y5 years | +141.8% | +171.2% |
SUPN Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.0% | at high | +42.4% |
| 5 y | 5 years | at high | +141.8% | at high | +171.2% |
| alltime | all time | at high | +354.7% | at high | +378.8% |
Supernus Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $541.10 M(+7.7%) |
| June 2024 | - | $502.60 M(+4.1%) |
| Mar 2024 | - | $482.69 M(+0.0%) |
| Dec 2023 | $482.56 M(+0.3%) | $482.56 M(+0.2%) |
| Sept 2023 | - | $481.39 M(-3.2%) |
| June 2023 | - | $497.36 M(-0.2%) |
| Mar 2023 | - | $498.19 M(+3.5%) |
| Dec 2022 | $481.25 M(+26.7%) | $481.25 M(+5.6%) |
| Sept 2022 | - | $455.76 M(+0.4%) |
| June 2022 | - | $454.01 M(+1.8%) |
| Mar 2022 | - | $446.15 M(+17.4%) |
| Dec 2021 | $379.92 M(+16.4%) | $379.92 M(+0.6%) |
| Sept 2021 | - | $377.48 M(+6.1%) |
| June 2021 | - | $355.92 M(+7.1%) |
| Mar 2021 | - | $332.19 M(+1.7%) |
| Dec 2020 | $326.50 M(+63.6%) | $326.50 M(+10.4%) |
| Sept 2020 | - | $295.73 M(+15.6%) |
| June 2020 | - | $255.73 M(+15.7%) |
| Mar 2020 | - | $221.07 M(+10.8%) |
| Dec 2019 | $199.55 M(+130.7%) | $199.55 M(+19.9%) |
| Sept 2019 | - | $166.42 M(+21.0%) |
| June 2019 | - | $137.56 M(+31.2%) |
| Mar 2019 | - | $104.83 M(+21.2%) |
| Dec 2018 | $86.49 M(-422.5%) | $86.49 M(+42.7%) |
| Sept 2018 | - | $60.60 M(+86.0%) |
| June 2018 | - | $32.59 M(+1660.6%) |
| Mar 2018 | - | $1.85 M(-106.9%) |
| Dec 2017 | -$26.82 M | -$26.82 M(-33.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | -$40.48 M(-28.3%) |
| June 2017 | - | -$56.44 M(-23.5%) |
| Mar 2017 | - | -$73.81 M(-12.4%) |
| Dec 2016 | -$84.29 M(-52.0%) | -$84.29 M(-14.5%) |
| Sept 2016 | - | -$98.61 M(-23.9%) |
| June 2016 | - | -$129.64 M(-7.2%) |
| Mar 2016 | - | -$139.65 M(-20.4%) |
| Dec 2015 | -$175.51 M(-7.4%) | -$175.51 M(+15.8%) |
| Sept 2015 | - | -$151.51 M(-2.7%) |
| June 2015 | - | -$155.73 M(-1.3%) |
| Mar 2015 | - | -$157.74 M(-16.7%) |
| Dec 2014 | -$189.45 M(+6.1%) | -$189.45 M(+16.2%) |
| Sept 2014 | - | -$163.01 M(-14.6%) |
| June 2014 | - | -$190.87 M(-1.6%) |
| Mar 2014 | - | -$194.07 M(+8.7%) |
| Dec 2013 | -$178.53 M(+107.0%) | -$178.53 M(+14.4%) |
| Sept 2013 | - | -$156.12 M(+18.3%) |
| June 2013 | - | -$132.03 M(+26.1%) |
| Mar 2013 | - | -$104.67 M(+21.3%) |
| Dec 2012 | -$86.25 M(+115.8%) | -$86.25 M(+18.6%) |
| Sept 2012 | - | -$72.74 M(+22.8%) |
| June 2012 | - | -$59.26 M(+20.3%) |
| Mar 2012 | - | -$49.25 M(+23.2%) |
| Dec 2011 | -$39.97 M(-57.4%) | -$39.97 M(-67.2%) |
| Sept 2011 | - | -$121.95 M(+30.0%) |
| Dec 2010 | -$93.79 M(+69.5%) | -$93.79 M(+10.1%) |
| Sept 2010 | - | -$85.21 M(+54.0%) |
| Dec 2009 | -$55.32 M(-0.8%) | -$55.32 M |
| Dec 2008 | -$55.78 M | - |
FAQ
- What is Supernus Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly retained earnings year-on-year change?
What is Supernus Pharmaceuticals annual retained earnings?
The current annual retained earnings of SUPN is $482.56 M
What is the all time high annual retained earnings for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual retained earnings is $482.56 M
What is Supernus Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of SUPN is $541.10 M
What is the all time high quarterly retained earnings for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly retained earnings is $541.10 M
What is Supernus Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, SUPN quarterly retained earnings has changed by +$58.54 M (+12.13%)